# 5-Amino-1MQ: Current Availability Status **By TelosRX Editorial Team** ยท 2026-09-21 **Telos rx does not currently offer 5-Amino-1MQ for compounding, and this article explains that status plainly, without speculation, along with what is actually available to patients today.** What to know 5-Amino-1MQ is not part of telos rx's current compounding program. It remains under review as part of the broader research peptide category telos rx continues to evaluate, alongside several other compounds with similar research-stage status. There is no confirmed date for when or whether that review concludes in favor of adding it. This article lays out that status clearly, honestly, and points to what telos rx does offer today for patients ready to begin. ## The direct answer You can read more about telos rx's current status on [5-Amino-1MQ](https://www.telosrx.com/pages/5-amino-1mq) directly. 5-Amino-1MQ is not currently offered for compounding at telos rx. It sits in the same review category as several other research peptides telos rx continues to evaluate, rather than being treated as an exception or a special case. ## Why availability is not just a yes or no switch Whether a compounding pharmacy can offer a substance depends on more than one factor lining up at the same time. Federal regulatory status, the strength of published safety data, and reliable sourcing through a partner compounding pharmacy all play a role. 5-Amino-1MQ has not cleared all of those factors, which is why it remains outside the current compounding program rather than moving forward on partial progress. ## What the 2026 committee review changed and did not change A 2026 committee review made non-binding recommendations regarding several research peptides, including some in a similar category to 5-Amino-1MQ. A non-binding recommendation is a formal opinion from an advisory body, not a rule change that compounding pharmacies must follow. It did not authorize telos rx or any compounding pharmacy to begin preparing 5-Amino-1MQ, and it has not changed what telos rx currently offers. ## How this differs from a temporary shortage It is worth separating this situation from a familiar one: a medication that is approved and normally available but temporarily out of stock. 5-Amino-1MQ is not in a shortage. It has not cleared the review and sourcing steps needed for a compounding pharmacy to prepare it in the first place. That distinction matters because a shortage typically resolves with restocking, while an unreviewed substance has no equivalent restocking event to wait for. ## What telos rx's review process actually considers Telos rx evaluates each research peptide against several factors together. Those are its regulatory status, the strength of available safety data, and whether reliable sourcing exists through partner compounding pharmacies. That review happens independently for each substance, so movement on one peptide does not automatically carry over to another, even a chemically related one. 5-Amino-1MQ's review sits within that broader, ongoing process rather than following any special or accelerated path. ## What a compounding pharmacy needs before it can prepare anything A compounding pharmacy cannot prepare a medication from raw material it cannot verify at pharmaceutical grade. Sourcing reliably, with consistent testing and documentation, is a separate operational requirement from whether a substance is legally permitted to compound. Partner compounding pharmacies need a dependable supply chain in place before any substance moves from reviewed to actually offered to patients. That operational piece is not always visible from outside the pharmacy relationship, but it is just as real a barrier as the regulatory question. ## Why telos rx will not speculate about a date It would be simple to publish a hopeful estimate about when 5-Amino-1MQ might become available. Some sellers do exactly that, to sustain interest in their own products. Telos rx takes a different approach, because a wrong estimate creates real problems for patients planning around it or seeking an unregulated source instead. The honest answer today is that no confirmed timeline exists, and telos rx will not manufacture one to satisfy demand for an answer. ## What would not count as evidence of a change A seller's claim that a peptide is now legal is not evidence of anything changing at telos rx. Neither is a forum post describing availability elsewhere, or a social media claim about upcoming approval. Telos rx bases its offerings on its own review, not on claims made by unrelated sellers or general online chatter about a substance's popularity. If 5-Amino-1MQ becomes part of the compounding program, that will appear directly on telos rx's own product pages first. **Key takeaway:** 5-Amino-1MQ is not currently offered by telos rx for compounding. It remains under review, with no confirmed timeline, and current availability is not affected by outside claims about the substance made by unrelated sellers. ## How current availability compares across the research peptide category 5-Amino-1MQ is one of several research peptides telos rx is reviewing at the same time. Those compounds have different proposed mechanisms and different evidence bases behind them. None of them currently has a confirmed date for potential inclusion, and each is evaluated on its own merits rather than as a group. That means one peptide's status changing would not necessarily signal anything about another's, even when they are frequently discussed together online. ## How this compares to a discontinued medication A medication that was once offered and later discontinued is a different situation from a substance that has never entered the compounding program. 5-Amino-1MQ has not been discontinued at telos rx, since it was never offered in the first place. That distinction avoids a common misunderstanding: this is not a product being pulled, it is one that has not yet met the bar to be added. ## How this landscape could shift over time Research peptide regulation is an evolving area, and committee reviews of this kind happen more than once, not as a single event. A substance's status today is not necessarily its status a year from now, in either direction. That is exactly why this article avoids predicting an outcome and instead points to telos rx's own pages as the place to check for anything that genuinely changes. ## What a real change would actually require Moving 5-Amino-1MQ from under review to available would require several things at once. Those are regulatory clarity beyond a non-binding recommendation, a completed internal review at telos rx, and confirmed reliable sourcing. All three would need to be in place before any protocol could actually launch. Partial progress on one factor does not translate into partial availability. The substance either meets telos rx's full bar for offering it, or it remains under review. ## A short summary of the status, stated plainly 5-Amino-1MQ is under review at telos rx, not available, not discontinued, and not scheduled. A non-binding committee recommendation exists, but it did not change what compounding pharmacies are permitted to prepare. No seller claim, forum post, or social media discussion changes that status either, no matter how confident the framing sounds. That is the complete, honest picture as of today, without added speculation in either direction. ## What patients researching this can reasonably do now If 5-Amino-1MQ interests you because of a metabolic health goal, say so plainly to a provider. Naming that goal is more useful than waiting on one specific compound to become available. A licensed provider can evaluate your history and discuss what is actually available and appropriate for you right now. Checking telos rx's own 5-Amino-1MQ page periodically is a reasonable way to stay informed without relying on secondhand claims. ## Where this leaves someone interested in metabolic support today Telos rx currently offers four compounded peptide options for patients ready to start today. Those are [BPC-157](https://www.telosrx.com/pages/bpc-157), [PT-141](https://www.telosrx.com/pages/pt-141), [NAD+ nasal spray](https://www.telosrx.com/pages/nad-nasal-spray), and [sermorelin](https://www.telosrx.com/pages/sermorelin). NAD+ nasal spray supports cellular energy metabolism and is available today through telos rx's partner compounding pharmacies with asynchronous intake. [Start an online visit for NAD+](https://start.telosrx.com/start-online-visit/peptides) if cellular energy support is the underlying goal that led you here. That is a different mechanism from NNMT inhibition specifically, and any treatment remains subject to medical approval by a licensed provider. For background on NNMT and metabolic research, see the [NIH review of NNMT as a metabolic target](https://pmc.ncbi.nlm.nih.gov/articles/PMC11196770/). For how compounded medication is regulated, see the [FDA overview of drug compounding](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers). ## Frequently Asked Questions ### Does telos rx currently sell 5-Amino-1MQ? No. 5-Amino-1MQ is not currently part of telos rx's compounding program. It remains under review as part of the broader research peptide category, with no confirmed timeline for that review concluding. ### Is 5-Amino-1MQ in a shortage at telos rx? No. It is not an approved medication experiencing a temporary supply issue. It has not yet cleared the review and sourcing steps a compounding pharmacy needs before offering any substance to patients. ### Did the 2026 committee review make 5-Amino-1MQ available? No. That review issued non-binding recommendations regarding several research peptides. A recommendation is not a regulatory approval, and it did not change what telos rx currently offers patients. ### When will 5-Amino-1MQ be available at telos rx? There is no confirmed timeline. Telos rx continues to review it, but will not publish a speculative date it cannot actually stand behind, even when patients would prefer a firm answer. ### How will I know if 5-Amino-1MQ becomes available? Telos rx's own product pages are the reliable source to check. Claims from unrelated sellers, forums, or social media about availability elsewhere are not evidence of anything changing at telos rx. ### What is available today if I want to start a protocol now? Telos rx currently offers BPC-157, PT-141, NAD+ nasal spray, and sermorelin as compounded, medically supervised options through partner compounding pharmacies with asynchronous intake. _TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. TelosRX operates as an online-first, asynchronous telehealth service._ Questions about what telos rx currently offers today? Explore [telos rx's 5-Amino-1MQ page](https://www.telosrx.com/pages/5-amino-1mq) for its current status, or visit [telosrx.com](https://telosrx.com) to see the full current product lineup and what is genuinely available right now for patients ready to begin. --- > Source: [Telos RX](https://www.telosrx.com/blogs/glp1/5-amino-1mq-current-availability-at-telos-rx)